Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.
The report details the trend, potential and market size of Short Bowel Syndrome market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Short Bowel Syndromemarket, defines the market attractiveness level of Short Bowel Syndrome market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Short Bowel Syndrome industry, describes the types of Short Bowel Syndrome market, the applications of major players and the market size, and deeply analyzes the current situation of the global Short Bowel Syndrome market and the development prospects and opportunities of Short Bowel Syndrome industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Short Bowel Syndrome market in Chapter 13.
By Player:
GlyPharma Therapeutics
Zealand Pharma
Emmaus Life Sciences
OxThera
Naia Pharmaceuticals
Nutrinia
Ardelyx
Shire
Merck
Sancilio & Company
By Type:
GLP-2
Growth Hormone
Glutamine
Others
By End-User:
Hospitals
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Short Bowel Syndrome Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Short Bowel Syndrome Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Short Bowel Syndrome Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Short Bowel Syndrome Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Short Bowel Syndrome Market Analysis and Outlook to 2022
-
7.1 Global Short Bowel Syndrome Consumption (2017-2022)
-
7.2 United States Short Bowel Syndrome Consumption (2017-2022)
-
7.3 Europe Short Bowel Syndrome Consumption (2017-2022)
-
7.4 China Short Bowel Syndrome Consumption (2017-2022)
-
7.5 Japan Short Bowel Syndrome Consumption (2017-2022)
-
7.6 India Short Bowel Syndrome Consumption (2017-2022)
-
7.7 South Korea Short Bowel Syndrome Consumption (2017-2022)
8 Region and Country-wise Short Bowel Syndrome Market Analysis and Outlook to 2028
-
8.1 Global Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.2 United States Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.3 Europe Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.4 China Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.5 Japan Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.6 India Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.7 South Korea Short Bowel Syndrome Consumption Forecast (2022-2028)
9 Global Short Bowel Syndrome Market Outlook by Types and Applications to 2022
-
9.1 Global Short Bowel Syndrome Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global GLP-2 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Growth Hormone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Glutamine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Short Bowel Syndrome Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global Short Bowel Syndrome Market Outlook by Types and Applications to 2028
-
10.1 Global Short Bowel Syndrome Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global GLP-2 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Glutamine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Short Bowel Syndrome Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Short Bowel Syndrome Import and Export Analysis (Top 5 Countries)
-
11.1 Global Short Bowel Syndrome Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Short Bowel Syndrome Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Short Bowel Syndrome Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Short Bowel Syndrome Market Competitive Analysis
-
14.1 GlyPharma Therapeutics
-
14.1.1 GlyPharma Therapeutics Company Details
-
14.1.2 GlyPharma Therapeutics Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlyPharma Therapeutics Short Bowel Syndrome Product and Service
-
14.2 Zealand Pharma
-
14.2.1 Zealand Pharma Company Details
-
14.2.2 Zealand Pharma Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Zealand Pharma Short Bowel Syndrome Product and Service
-
14.3 Emmaus Life Sciences
-
14.3.1 Emmaus Life Sciences Company Details
-
14.3.2 Emmaus Life Sciences Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Emmaus Life Sciences Short Bowel Syndrome Product and Service
-
14.4 OxThera
-
14.4.1 OxThera Company Details
-
14.4.2 OxThera Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 OxThera Short Bowel Syndrome Product and Service
-
14.5 Naia Pharmaceuticals
-
14.5.1 Naia Pharmaceuticals Company Details
-
14.5.2 Naia Pharmaceuticals Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Naia Pharmaceuticals Short Bowel Syndrome Product and Service
-
14.6 Nutrinia
-
14.6.1 Nutrinia Company Details
-
14.6.2 Nutrinia Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Nutrinia Short Bowel Syndrome Product and Service
-
14.7 Ardelyx
-
14.7.1 Ardelyx Company Details
-
14.7.2 Ardelyx Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Ardelyx Short Bowel Syndrome Product and Service
-
14.8 Shire
-
14.8.1 Shire Company Details
-
14.8.2 Shire Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Shire Short Bowel Syndrome Product and Service
-
14.9 Merck
-
14.9.1 Merck Company Details
-
14.9.2 Merck Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck Short Bowel Syndrome Product and Service
-
14.10 Sancilio & Company
-
14.10.1 Sancilio & Company Company Details
-
14.10.2 Sancilio & Company Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sancilio & Company Short Bowel Syndrome Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Short Bowel Syndrome
-
Figure Short Bowel Syndrome Picture
-
Table Global Short Bowel Syndrome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Short Bowel Syndrome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Short Bowel Syndrome Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure United States Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table Europe Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure China Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Japan Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure India Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure South Korea Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure United States Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GLP-2 Consumption and Growth Rate (2017-2022)
-
Figure Global Growth Hormone Consumption and Growth Rate (2017-2022)
-
Figure Global Glutamine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global GLP-2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glutamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Short Bowel Syndrome Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Short Bowel Syndrome Export by Region (Top 5 Countries) (2017-2028)
-
Table GlyPharma Therapeutics (Foundation Year, Company Profile and etc.)
-
Table GlyPharma Therapeutics Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlyPharma Therapeutics Short Bowel Syndrome Product and Service
-
Table Zealand Pharma (Foundation Year, Company Profile and etc.)
-
Table Zealand Pharma Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zealand Pharma Short Bowel Syndrome Product and Service
-
Table Emmaus Life Sciences (Foundation Year, Company Profile and etc.)
-
Table Emmaus Life Sciences Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emmaus Life Sciences Short Bowel Syndrome Product and Service
-
Table OxThera (Foundation Year, Company Profile and etc.)
-
Table OxThera Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table OxThera Short Bowel Syndrome Product and Service
-
Table Naia Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Naia Pharmaceuticals Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Naia Pharmaceuticals Short Bowel Syndrome Product and Service
-
Table Nutrinia (Foundation Year, Company Profile and etc.)
-
Table Nutrinia Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nutrinia Short Bowel Syndrome Product and Service
-
Table Ardelyx (Foundation Year, Company Profile and etc.)
-
Table Ardelyx Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ardelyx Short Bowel Syndrome Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Short Bowel Syndrome Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Short Bowel Syndrome Product and Service
-
Table Sancilio & Company (Foundation Year, Company Profile and etc.)
-
Table Sancilio & Company Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sancilio & Company Short Bowel Syndrome Product and Service
-
